{"id":69475,"name":"BURRELL INTERNATIONAL GROUP (ON BEHALF OF AMO PHARMA)","slug":"burrell-international-group-on-behalf-of-amo-pharma","state":null,"country":"United Kingdom","description":"Life Sciences R&D","totalSpending":0,"filings":3,"yearlySpending":[{"year":2025,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["TRUSYNERGY"],"lobbyists":["MARK LENKER"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Rare disease issues; FDA policies","Clinical trial guidance for ultra-rare and rare diseases."]}